SCHEMBL8560803

SCHEMBL8560803

COc1ccccc1N1CCN(CC#CCN)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.59
DRD3 P35462 3/20 0.57
HTR7 P34969 2/20 0.56
DRD4 P21917 1/20 0.56
HRH2 P25021 1/20 0.56
HRH1 P35367 1/20 0.56
ADRA1D P25100 1/20 0.56
ADRA1A P35348 1/20 0.56
ADRA1B P35368 1/20 0.56
HTR1A P08908 1/20 0.56
KDM4E B2RXH2 4/20 0.54
MAPK1 P28482 2/20 0.54
LMNA P02545 2/20 0.54
HTT P42858 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 1/20 0.53
KMT2A Q03164 1/20 0.53
MAPT P10636 1/20 0.52
ALOX15 P16050 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2976824 0.85 DRD2 (0.58) DRD2DRD3HTR7DRD4HRH2
Hydrochloric Acid SCHEMBL2988937 0.85 DRD2 (0.58) DRD2DRD3HTR7DRD4HRH2
SCHEMBL6031843 0.81 DRD2 (0.64) DRD2DRD3HTR7DRD4HRH2
SCHEMBL8606553 0.81 DRD2 (0.64) DRD2DRD3HTR7DRD4HRH2
SCHEMBL8569200 0.81 DRD2 (0.69) DRD2DRD3HTR7ADRA1DADRA1A
SCHEMBL7269404 0.80 KDM4E (0.53) DRD2DRD3HTR7DRD4HTR1A
Hydrochloric Acid SCHEMBL8570034 0.80 DRD2 (0.67) DRD2DRD3HTR7ADRA1DADRA1A
SCHEMBL5800584 0.80 HTR1A (0.62) DRD2HTR7ADRA1DADRA1AADRA1B
SCHEMBL4404160 0.80 DRD2 (0.75) DRD2DRD3HTR7ADRA1DADRA1A
Hydrochloric Acid SCHEMBL5801035 0.79 HTR1A (0.61) DRD2HTR7ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5334715-A For treating psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US claimed
EP-0494604-B1 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-10-07 EP disclosed
EP-0511610-B1 Benzisothiazole- and benzisoxazole-3-carboxamides, a process for their preparation and their use as antipsychotic medicaments HOECHST ROUSSEL PHARMA (US) 1996-09-11 EP disclosed
US-5440048-A Treating psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC (US) 1995-08-08 US disclosed
US-5334715-A For treating psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US disclosed
US-5225412-A Antipsychotic HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-07-06 US disclosed
US-5194436-A For trating psychosis HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-03-16 US disclosed
EP-0511610-A1 Benzisothiazole- and benzisoxazole-3-carboxamides, a process for their preparation and their use as antipsychotic medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-11-04 EP disclosed
US-5143923-A Psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-09-01 US disclosed
EP-0494604-A1 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-07-15 EP disclosed
US-5130315-A Treatment of psychosis Wittekind, Raymond R. (US) 1992-07-14 US disclosed